PTC Therapeutics Inc. buy Quitte
Start price
03.03.16
/
50%
€5.86
Target price
05.09.16
€8.03
Performance (%)
21.69%
End price
05.09.16
€7.13
Summary
This prediction ended on 05.09.16 with a price of €7.13. The BUY prediction by Quitte finished with a performance of 21.69%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| PTC Therapeutics Inc. | -2.248% | -2.248% | 38.057% | 24.487% |
| iShares Core DAX® | -0.372% | 8.404% | 6.759% | 47.912% |
| iShares Nasdaq 100 | 2.269% | 15.232% | 36.176% | 94.084% |
| iShares Nikkei 225® | 1.433% | 14.424% | 43.114% | 64.804% |
| iShares S&P 500 | 1.216% | 10.492% | 27.276% | 66.763% |
Comments by Quitte for this prediction
In the thread PTC Therapeutics Inc. diskutieren
chancenreich
die ist nicht so schlecht wie der Absturz vermuten lässt
PTC Therapeutics (NASDAQ: PTCT) recently received a number of ratings updates from brokerages and research firms:
- 3/1/2016 – PTC Therapeutics had its price target raised by analysts at Barclays from $40.00 to $100.00. They now have an “overweight” rating on the stock.
- 3/1/2016 – PTC Therapeutics had its “outperform” rating reaffirmed by analysts at Credit Suisse. They now have a $12.00 price target on the stock, down previously from $36.00. etc etc
(Laufzeit überschritten)